Related Experiment Video
Updated: May 23, 2026

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy
Published on: July 20, 2022
Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient
Ingrid Hopper1, William Kemp, Pornwalee Porapakkham
1Department of Clinical Pharmacology and Therapeutics, The Alfred Center, Melbourne, Australia. ingrid.hopper@monash.edu
Insights
Cardiac dysfunction increases liver stiffness (LSM) as measured by FibroScan(®), indicating potential liver issues in heart failure patients. Acute volume changes did not significantly alter LSM measurements in this study.
Area of Science:
- Cardiology
- Hepatology
- Medical Diagnostics
Background:
- Cardiac dysfunction can lead to cardiac hepatopathy, potentially causing hepatic fibrosis or cirrhosis.
- The reliability of non-invasive tools like FibroScan(®) for assessing liver stiffness (LSM) in cardiac dysfunction is not well-established.
- Understanding LSM variations in heart failure is crucial for managing liver complications.
Purpose of the Study:
- To evaluate the impact of cardiac dysfunction on liver stiffness measurements (LSM) using FibroScan(®).
- To investigate the influence of acute volume status changes on LSM in patients with heart failure and in those undergoing hemodialysis.
Main Methods:
- A prospective, cross-sectional study involving patients with left-sided heart failure (LHF), right-sided heart failure (RHF), and acute decompensated heart failure (ADHF).
- Liver stiffness was measured using FibroScan(®) in patient groups and compared to healthy controls.
- LSM was reassessed after diuresis in ADHF patients and after ultrafiltration in a hemodialysis (HD) group to assess the impact of volume changes.
Main Results:
- Patients with LHF, RHF, and ADHF showed significantly increased LSM compared to healthy controls.
- Specifically, RHF and ADHF groups exhibited markedly elevated LSM.
- Diuresis in ADHF patients and ultrafiltration in HD patients did not result in statistically significant alterations in LSM.
Conclusions:
- Increased liver stiffness measurements are observed in patients with cardiac dysfunction.
- Acute changes in volume status do not appear to significantly affect LSM readings in the context of heart failure or hemodialysis.
Aim:
The impact of cardiac dysfunction on the liver is known as cardiac hepatopathy. In certain instances this can result in significant hepatic fibrosis or cirrhosis. The validity of non-invasive tools to assess hepatic fibrosis, such as FibroScan(®) which measures liver stiffness (LSM), has not been established in this setting. We examined the impact of cardiac dysfunction on LSM using FibroScan(®) and the influence of volume changes on LSM.
Methods And Results:
A prospective, cross-sectional study examined the use of FibroScan(®) in subjects with left-sided heart failure (LHF, n = 32), right-sided heart failure (RHF, n = 9), and acute decompensated heart failure (ADHF, n = 8). The impact of volume changes upon LSM was further examined in the ADHF group (pre- and post-diuresis) and in a haemodialysis group (HD, n = 12), pre- and post-ultrafiltration on dialysis. Compared with healthy controls [n = 55, LSM = median 4.4 (25th percentile 3.6, 75th percentile 5.1) kPa], LSM was increased in all the cardiac dysfunction subgroups [LHF, 4.7 (4.0, 8.7) kPa, P = 0.04; RHF, 9.7 (5.0, 10.8) kPa, P < 0.001; ADHF, 11.2 (6.7, 14.3) kPa, P < 0.001]. Alteration in volume status via diuresis did not change the baseline LSM in ADHF [11.2 (6.7, 14.3) to 9.5 (7.3, 21.6) kPa, P > 0.05] with mean diuresis 5051 ± 1585 mL, or ultrafiltration in HD [6.0 (3.6, 5.1) vs. 5.7 (4.8, 7.0) kPa, P > 0.05] with mean diuresis 1962 ± 233 mL.
Conclusion:
Our findings support the concept of increased LSM in the cardiac failure population. LSM was not altered to a statistically significant level with acute volume changes.
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Heart Failure III: Clinical Manifestations
